The global in vitro diagnostics market is projected to reach $157.63 billion by 2030, growing at a 7.6% CAGR, driven by chronic disease rates and advances in immunoassays.
Read More
Sysmex’s CN-Series analyzers and CN-9000 automation platform illustrate broader shifts in hemostasis testing, including workflow integration, throughput, and quality control.
Read More
A Mayo Clinic study of 674 trauma patients found elevated circulating nucleosome levels in those who developed venous thromboembolism, suggesting a potential new biomarker for early VTE risk identification.
Read More
ViewsML will present an AI platform at USCAP 2026 that predicts biomarker expression from standard H&E slides, enabling per-cell spatial analysis without additional staining, according to the company.
Read More
The Pennsylvania-based laboratory will integrate Ibex’s AI solution for prostate biopsies and TURP specimens into its existing digital pathology infrastructure.
Read More